64 190

Cited 7 times in

Concurrent chemoradiotherapy in cervical cancer (a new paradigm in cervical cancer treatment).

Authors
Ryu, HS
Citation
Yonsei medical journal, 43(6):749-753, 2002
Journal Title
Yonsei medical journal
ISSN
0513-57961976-2437
Abstract
During the last century, the mainstay for the treatment of uterine cervix cancer has been via two main primary treatment modalities, these being radical surgery (radical hysterectomy and regional lymph nodes dissection) and radiotherapy. Generally, radical surgery is restricted to stages I and IIa of FIGO (the International Federation of Gynecology and Obstetrics) Classification, while radiotherapy may be applied to all stages of cervical cancer. In 1999 the National Cancer Institute Clinical Announcement established concurrent chemoradiotherapy as a new primary treatment modality, which is the focus of this review.
MeSH terms
Combined Modality TherapyFemaleHumansUterine Cervical Neoplasms/*therapy
DOI
10.3349/ymj.2002.43.6.749
PMID
12497658
Appears in Collections:
Journal Papers > School of Medicine / Graduate School of Medicine > Obstetrics & Gynecology
AJOU Authors
유, 희석
Full Text Link
Files in This Item:
ymj-43-749.pdfDownload
Export
RIS (EndNote)
XLS (Excel)
XML

qrcode

해당 아이템을 이메일로 공유하기 원하시면 인증을 거치시기 바랍니다.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse